Effect of Tenofovir on Genital HSV Shedding: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Latest Information Update: 17 Feb 2023
At a glance
- Drugs Tenofovir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Herpes genitalis; Herpes simplex virus type 2 infections
- Focus Therapeutic Use
- 04 Jun 2014 Planned End Date changed from 1 Dec 2013 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 04 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Mar 2012 New source identified and integrated (41250A; University of Washington Health Sciences).